Literature DB >> 11005566

Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer.

T Yamaura1, K Murakami, Y Doki, S Sugiyama, T Misaki, Y Yamada, I Saiki.   

Abstract

We examined the tumorigenic and metastatic potentials of three human non-small cell lung cancer (NSCLC) cell lines, PC-14, A549 or Lu-99 cell lines suspended in Matrigel-containing phosphate-buffered saline were orthotopically implanted into the lungs of nude mice. The formation of a solitary tumor nodule in the lung was observed after the implantation of all cell lines. Intrapulmonary implantation of PC-14 or Lu-99 cells resulted in spontaneous distant metastases. In contrast, A549 cells caused multiple intrapulmonary metastases to the right and left lobes of the lung without producing visible lymphatic metastasis. We also investigated the expression of matrix metalloproteinases (MMPs), urokinase-type plasminogen activator (u-PA), u-PA receptor (u-PAR) and c-MET in these cell lines in vitro and in vivo. Reverse transcription polymerase chain reaction (RT-PCR) analysis showed that the expression of MMP-2 and membrane-type 1 MMP (MT1-MMP) was elevated in PC-14 as compared with the other two cell lines. In contrast, stronger expression of c-MET was observed in A549 than in PC-14 or Lu-99. These results indicate that differential patterns of metastasis of lung cancer might be associated with differential expression of metastasis-associated molecules. Our orthotopic implantation models display clinical features resembling those of NSCLC, and may provide a useful basis for lung cancer research.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005566      PMCID: PMC1550292          DOI: 10.1038/sj.neo.7900098

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  42 in total

1.  The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.

Authors:  G S Butler; M J Butler; S J Atkinson; H Will; T Tamura; S Schade van Westrum; T Crabbe; J Clements; M P d'Ortho; G Murphy
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

2.  Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

Authors:  R Mazzieri; L Masiero; L Zanetta; S Monea; M Onisto; S Garbisa; P Mignatti
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

3.  Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).

Authors:  T Hayashi; M V Fleming; W G Stetler-Stevenson; L A Liotta; J Moss; V J Ferrans; W D Travis
Journal:  Hum Pathol       Date:  1997-09       Impact factor: 3.466

4.  Revisions in the International System for Staging Lung Cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

5.  Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group.

Authors:  J F Vansteenkiste; P R De Leyn; G J Deneffe; G Stalpaert; K L Nackaerts; T E Lerut; M G Demedts
Journal:  Ann Thorac Surg       Date:  1997-05       Impact factor: 4.330

Review 6.  The urokinase-type plasminogen activator system in cancer metastasis: a review.

Authors:  P A Andreasen; L Kjøller; L Christensen; M J Duffy
Journal:  Int J Cancer       Date:  1997-07-03       Impact factor: 7.396

7.  Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung.

Authors:  M Kodate; T Kasai; H Hashimoto; K Yasumoto; Y Iwata; H Manabe
Journal:  Pathol Int       Date:  1997-07       Impact factor: 2.534

8.  Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.

Authors:  N Kawano; H Osawa; T Ito; Y Nagashima; F Hirahara; Y Inayama; Y Nakatani; S Kimura; H Kitajima; N Koshikawa; K Miyazaki; H Kitamura
Journal:  Hum Pathol       Date:  1997-05       Impact factor: 3.466

9.  The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis.

Authors:  T Naruke; T Goya; R Tsuchiya; K Suemasu
Journal:  Ann Thorac Surg       Date:  1988-12       Impact factor: 4.330

10.  Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

Authors:  L Naldini; K M Weidner; E Vigna; G Gaudino; A Bardelli; C Ponzetto; R P Narsimhan; G Hartmann; R Zarnegar; G K Michalopoulos
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  5 in total

1.  Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models.

Authors:  Diego Luis-Ravelo; Iker Antón; Silvestre Vicent; Igor Hernández; Karmele Valencia; Carolina Zandueta; Susana Martínez-Canarias; Alfonso Gúrpide; Fernando Lecanda
Journal:  Clin Exp Metastasis       Date:  2011-07-28       Impact factor: 5.150

2.  LPP inhibits collective cell migration during lung cancer dissemination.

Authors:  S Kuriyama; M Yoshida; S Yano; N Aiba; T Kohno; Y Minamiya; A Goto; M Tanaka
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

3.  An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients.

Authors:  Sanaz Taromi; Gian Kayser; Dominik von Elverfeldt; Wilfried Reichardt; Friederike Braun; Wolfgang A Weber; Robert Zeiser; Meike Burger
Journal:  Clin Exp Metastasis       Date:  2016-07-06       Impact factor: 5.150

4.  Antitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model in vivo.

Authors:  Ji-Ye Kee; Yoshihisa Arita; Kanna Shinohara; Yasukata Ohashi; Hiroaki Sakurai; Ikuo Saiki; Keiichi Koizumi
Journal:  Mol Clin Oncol       Date:  2012-09-28

5.  Synthetic extracellular matrix enhances tumor growth and metastasis in an orthotopic mouse model of pancreatic adenocarcinoma.

Authors:  Courtney L Scaife; Jill E Shea; Qiang Dai; Matthew A Firpo; Glenn D Prestwich; Sean J Mulvihill
Journal:  J Gastrointest Surg       Date:  2007-12-05       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.